Huah Shin Ng
Title
Cited by
Cited by
Year
Comorbidity, physical and mental health among cancer patients and survivors: an Australian population‐based study
HS Ng, D Roder, B Koczwara, A Vitry
Asia‐Pacific Journal of Clinical Oncology 14 (2), e181-e192, 2018
342018
Assessment of the therapeutic value of new medicines marketed in Australia
AI Vitry, NH Shin, P Vitre
Journal of pharmaceutical policy and practice 6 (1), 1-6, 2013
312013
Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study
HS Ng, B Koczwara, D Roder, A Vitry
Prostate cancer and prostatic diseases 21 (3), 403-410, 2018
242018
Patterns of comorbidities in women with breast cancer: a Canadian population-based study
HS Ng, A Vitry, B Koczwara, D Roder, ML McBride
Cancer Causes & Control 30 (9), 931-941, 2019
232019
Comorbidities in Australian women with hormone‐dependent breast cancer: a population‐based analysis
HS Ng, B Koczwara, DM Roder, T Niyonsenga, AI Vitry
Medical Journal of Australia 208 (1), 24-28, 2018
132018
Changes in the prevalence of comorbidity in the Australian population with cancer, 2007–2014
HS Ng, B Koczwara, D Roder, A Vitry
Cancer epidemiology 54, 56-62, 2018
92018
Incidence of comorbidities in women with breast cancer treated with tamoxifen or an aromatase inhibitor: an Australian population-based cohort study
HS Ng, B Koczwara, D Roder, T Niyonsenga, A Vitry
Journal of comorbidity 8 (1), 16-24, 2018
92018
Safety profile of ocrelizumab for the treatment of multiple sclerosis: a systematic review
HS Ng, CL Rosenbult, H Tremlett
Expert Opinion on Drug Safety 19 (9), 1069-1094, 2020
82020
Adherence to laboratory monitoring among people taking oral drugs for multiple sclerosis: A Canadian population-based study
HS Ng, E Kingwell, F Zhu, T Zhang, RA Marrie, R Carruthers, H Tremlett
Multiple Sclerosis Journal 27 (2), 239-249, 2021
42021
Prevalence of Comorbidities and Health Status among Current Cancer and Cancer Survivors: An Australian Population-Based Study
HS Ng, D Roder, A Vitry
Value in Health 19 (7), A884-A885, 2016
22016
Safety of dimethyl fumarate for multiple sclerosis: A systematic review and meta-analysis
G Liang, J Chai, HS Ng, H Tremlett
Multiple Sclerosis and Related Disorders, 102566, 2020
12020
Patterns of health service utilisation among the Australian population with cancer compared with the general population
HS Ng, B Koczwara, D Roder, RJ Chan, A Vitry
Australian Health Review 44 (3), 470-479, 2019
12019
Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare setting
HS Ng, F Zhu, E Kingwell, Y Zhao, S Yao, O Ekuma, LW Svenson, ...
Expert Review of Neurotherapeutics 21 (1), 131-140, 2021
2021
Characteristics of a population exposed to a disease-modifying drug for multiple sclerosis in the real-world setting (1996-2017)
HS Ng, F Zhu, E Kingwell, Y Zhao, C Evans, L Svenson, J Fisk, RA Marrie, ...
MULTIPLE SCLEROSIS JOURNAL 26 (3_ SUPPL), 330-331, 2020
2020
Adherence to laboratory monitoring among people taking oral drugs for multiple sclerosis: A population-based study
HS Ng, E Kingwell, F Zhu, T Zhang, RA Marrie, R Carruthers, H Tremlett
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 477-477, 2020
2020
Alemtuzumab and prescription medication use in the MS population
A Chertcoff, HS Ng, F Zhu, Y Zhao, E Kingwell, H Tremlett
Multiple sclerosis and related disorders 42, 102086, 2020
2020
Adherence To Laboratory Monitoring In Patients Taking Oral Drugs For Multiple Sclerosis: A Population-based Study
H Ng, E Kingwell, F Zhu, T Zhang, R Marrie, R Carruthers, H Tremlett
MULTIPLE SCLEROSIS JOURNAL 26 (1_ SUPPL), 63-64, 2020
2020
Patterns of comorbidities in women with breast cancer: a Canadian population-based study
HS Ng, A Vitry, B Koczwara, D Roder, M McBride
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 14, 75-75, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–18